• Manage the day-to-day operations of the IT infrastructure group, including desktop/laptop, desk/cell phones, server, and network support. • Manage vendor relationships, Service Level Agreements, assets and budgets for infrastructure hardware, sof...

Senior Application Developer: Department: Information Technology Position Title: Senior Application Developer Reports to Manager’s Title: Vice President, Information Technology Location: Exton Corporate FL...

The Executive Director, Procurement and Strategic Sourcing, under general supervision, for the continued development and leading the procurement program of the company, including the identification of new sources of supply that provide strategic benefit i...

RESPONSIBILITIES: The Lead Analyst will contribute to the completion of specific projects/studies. Provide extensive technical expertise as part of the Statistical Programming (SP) team to develop, test, maintain, validate, and document programs to...

Perform statistical programming to support statistical analysis of the clinical data and submission to regulatory agencies. ESSENTIAL DUTIES AND RESPONSIBILITIES Generate data listings, tables and figures (TFL) from clinical data, using S...

GENERAL SUMMARY: ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE:LLY), is committed to advancing oncology care by developing a portfolio of targeted biologic treatments designed to address the medical needs of patients wi...

GENERAL SUMMARY ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE:LLY), is committed to advancing oncology care by developing a portfolio of targeted biologic treatments designed to address the medical needs of patients wit...

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, is committed to advancing oncology care by developing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. Founded in ...

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE:LLY), is committed to advancing oncology care by developing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. ...

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE:LLY), is committed to advancing oncology care by developing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. ...

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE:LLY), is committed to advancing oncology care by developing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. ...

OSI Pharmaceuticals is committed to “shaping medicines and changing lives” by discovering, developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, ...

OSI Pharmaceuticals is committed to “shaping medicines and changing lives” by discovering, developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, ...

OSI Pharmaceuticals is committed to “shaping medicines and changing lives” by discovering, developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, ...

OSI Pharmaceuticals is committed to “shaping medicines and changing lives” by discovering, developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, ...